Plain-English translation of ·
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This is a large research study testing whether two medications— and terazosin—can slow down Parkinson's disease when added to your current treatment. The trial uses a smart design where multiple treatments are tested at the same time, with researchers checking progress regularly to see which ones are working best. Some participants will receive one of these medications, while others receive a placebo (a dummy pill with no active ingredient) to compare results.
Current Parkinson's treatments help with symptoms but lose effectiveness over time and can cause serious side effects. This trial exists because researchers believe the medication being tested might actually slow the disease's progression, rather than just manage symptoms—which could make a real difference in how the disease affects your life over time.
You likely qualify if…
You likely don't qualify if…
You'll start with one in-person screening visit at the clinic. After that, you can do almost everything remotely—visiting at 3 months, 6 months, then every 6 months after that for up to 3 years. You'll either receive one of the test medications or a placebo added to your regular Parkinson's care, and the research team will check in regularly to monitor how you're doing and watch for any side effects.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
United Kingdom